Famotidine Dosing with Ibuprofen for Gastroprotection
For gastric protection when taking ibuprofen, use famotidine 26.6 mg three times daily, co-administered with each ibuprofen 800 mg dose.
Recommended Dosing Regimen
The FDA-approved fixed-dose combination tablet contains ibuprofen 800 mg and famotidine 26.6 mg, taken three times daily 1. This represents approximately double the standard famotidine dose used for other indications, specifically designed to provide gastroprotection during chronic NSAID therapy.
Key Dosing Points:
- Standard dose: Famotidine 26.6 mg with each ibuprofen 800 mg dose
- Frequency: Three times daily
- Timing: Can be taken with or without food 1
- May be co-administered with antacids if needed 1
Evidence for This Dosing Strategy
The REDUCE-1 and REDUCE-2 trials demonstrated that this specific combination significantly reduces upper GI ulcer risk compared to ibuprofen alone 2. In pooled analysis:
- Upper GI ulcers reduced by 51-59% depending on age group 3
- Gastric ulcers: 12.5% vs 20.7% (combination vs ibuprofen alone)
- Duodenal ulcers: 1.1% vs 5.1% (combination vs ibuprofen alone) 2
The hazard ratio for upper GI ulcers with this combination versus ibuprofen alone was 0.46 (95% CI: 0.34-0.61), representing a 54% risk reduction 2.
Why This Specific Dose?
This famotidine dose (26.6 mg TID = ~80 mg daily) is double the standard H2-blocker dose typically used for other indications. Standard famotidine dosing for conditions like GERD is 20 mg twice daily 1. The higher dose was specifically studied and proven effective for NSAID gastroprotection 2, 4.
Renal Dosing Adjustments
If creatinine clearance is impaired, adjust as follows 1:
- CrCl 30-60 mL/min: Maximum 20 mg once daily (requires switching from combination tablet to separate formulations)
- CrCl <30 mL/min: Maximum 20 mg every other day
Clinical Context from Guidelines
While the provided guidelines 5, 6 emphasize that NSAIDs should be used at the lowest effective dose for the shortest duration, they also recognize that gastroprotective therapy is essential for at-risk patients. Risk factors include:
- Prior peptic ulcer disease (2-4 fold increased risk) 5
- Age >60 years (4% increased risk per year of age) 5
- Concomitant aspirin, anticoagulants, or corticosteroids 5
- High-dose or multiple NSAIDs 5
Important Caveats
Timing with aspirin: If the patient takes low-dose aspirin for cardioprotection, ibuprofen should be taken either ≥30 minutes after immediate-release aspirin or ≥8 hours before aspirin to avoid interference with aspirin's antiplatelet effects 6. Note that combining aspirin with any NSAID increases GI bleeding risk over 10-fold 5.
Duration: The combination was studied for up to 54 weeks and showed sustained safety and tolerability 7. However, per guideline recommendations, use the shortest duration necessary 6.
Limitations of protection: This regimen reduces but does not eliminate ulcer risk. Even with famotidine, approximately 10-13% of patients developed upper GI ulcers over 24 weeks 3, 2.